Headline News

 

USFDA Final Approval Received by Alembic Pharmaceuticals for Vilazodone Hydrochloride Tablets, 10 mg, 20 mg, and 40 mg.

Posted on January 14, 2020

J. Alan Butcher Appointed as Lupin’s Chief Corporate Development Officer

Posted on January 14, 2020

Topline Results for TRILOGY 1 Phase 3 Trial of CaPre Reported by Acasti Pharma

Posted on January 14, 2020

Pfizer’s Novel Clinical Stage Asset with Application in Alzheimer’s Disease and Parkinson’s Disease to be Acquired by Biogen

Posted on January 14, 2020

ANDA Approval received by Glenmark Pharmaceuticals for Deferasirox Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg

Posted on January 14, 2020

To Broaden Patient Access to Genomic Testing, Roche and Illumina Partner

Posted on January 14, 2020

Global Diagnostic Collaborations Announced by Amgen To Expand Molecular Testing For Patients With Non-Small Cell Lung Cancer

Posted on January 14, 2020

Large-Scale Oligonucleotide Manufacturing Facility Opened by WuXi STA

Posted on January 07, 2020

Merger Agreement Between Illumina and Pacific Biosciences to be Terminated

Posted on January 07, 2020

Biocon Biologics to Receive Investment of Rs 536.25 Crore from True North for 2.44% Stake

Posted on January 07, 2020

Merck Announces Phase 3 KEYNOTE-604 Trial Investigating KEYTRUDA

Posted on January 07, 2020

ANDA approval received by Glenmark Pharmaceuticals for Deferasirox Tablets for Oral Suspension, 125 mg, 250 mg and 500 mg

Posted on January 07, 2020

Purchase Completed by Catalent of Biologics Fill-Finish and Oral Solid Dose Facility in Anagni, Italy

Posted on January 07, 2020

Former Celgene China GM John Chin Appointed as Antengene Corporation’s Chief Business Officer

Posted on January 07, 2020

Xyphos Biosciences, Inc. Acquired by Astellas to Strengthen Immuno-oncology Pipeline

Posted on January 07, 2020